Labshake search
Citations for Bio X Cell :
1 - 50 of 167 citations for CTLA 4 Human HEK293 GST since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Immunology 2021Quote: ... and CTLA-4 blocking antibody (clone 9D9, BioXCell, cat. BE0164) were administered either in combination or as single agents at 100ug/antibody/mouse every third day starting on the day of doxycycline diet addition for four total doses.
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and anti-CTLA-4 (clone 9D9, Bio X Cell, #BE0164) were performed as part of this study ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 200 ug anti-CTLA-4 (BioXcell, catalog #BE0164, clone 9D9) at days 9 and 12 after organoid implantation ...
-
bioRxiv - Immunology 2024Quote: ... and 200µg of anti-mouse CTLA-4 antibody (9H10 clone, BioXCell), using purified Rat IgG2a,κ isotype control antibody (RTK2758 clone ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 75µg of anti-CTLA-4 (9H10) antibody or IgG equivalent (BioXCell). Treatments continued every three days until the end of the experiment (maximum tumor growth of 15 mm diameter for control groups) ...
-
bioRxiv - Immunology 2022Quote: ... mice were treated with 250 ug/dose of CTLA-4 Ig (BioXCell) and anti-ICOS (BioXCell ...
-
bioRxiv - Immunology 2023Quote: ... 500 µg of anti-CTLA-4 antibody (clone UC10-4F10-11, BioXCell) or hamster IgG isotype control antibody (clone PIP ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Cancer Biology 2020Quote: ... or isotype control (MSD IgG1 control for muDX400, BioXCell, BE0086 for CTLA-4) treatments were administered on days 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and/or 5 mg/kg anti-CTLA-4 (clone 9H10, cat. BE0131, BioXcell). Antibodies were dissolved in PBS and administered via intraperitoneal injection (4 μl/g ...
-
bioRxiv - Pathology 2020Quote: ... and 200 μg of InVivoMab recombinant CTLA-4-Ig (hum/hum; Bio X Cell) on day 2 post-transplantation [17 ...
-
bioRxiv - Immunology 2022Quote: ... mice were treated intraperitoneally with 0.15 mg anti-CTLA-4 mAb (clone 9H10, BioxCell) or polyclonal Syrian Hamster IgG control (BioxCell ...
-
bioRxiv - Cancer Biology 2023Quote: ... mice were randomized and treated with mouse anti-CTLA-4 (BioXCell, BP0164, clone 9D9) or mouse IgG2b as isotype control (BioXcell ...
-
bioRxiv - Immunology 2023Quote: ... 750 μg of anti-CTLA-4 antibody clone UC10-4F10-11 (Bio X Cell) or hamster IgG isotype control antibody (clone PIP ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Immunology 2023Quote: ... or anti-CTLA-4 (200 μg/100 μL; clone 9D9; cat. #BE0164; Bio X Cell) or anti-LAG-3 (200 μg/100 μL ...
-
bioRxiv - Immunology 2023Quote: ... 100 µg/ml of anti-CTLA-4 antibody (clone UC10-4F10-11, Bio X Cell) or 25 nM Bafilomycin A1 (Sigma-Aldrich ...
-
bioRxiv - Immunology 2023Quote: Mice were injected intraperitoneally with anti-CTLA-4 (clone UC10-4F10-11, Bio X Cell) and anti- PD-L1 (clone 10F.9G2 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-murine PD-1 and anti-murine CTLA-4 were purchased from Bio X Cell (BE0146-clone RMP1-14 ...
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Bioengineering 2023Quote: ... anti-mouse CTLA-4 (BE0131) and anti-mouse PD-L1 (BE0101) antibodies were purchased from Bioxcell (Lebanon, NH). Anti-human PD-L1 antibody (10084-R639) ...
-
bioRxiv - Immunology 2020Quote: ... Mice were injected with 100µg of anti–CTLA-4 mAb (#BE0164, clone 9D9, Bio X Cell, West Lebanon, NH) or isotype control (#BE0086 ...
-
bioRxiv - Immunology 2022Quote: For checkpoint blockade therapy 100 μg each of anti-CTLA-4 (Clone UC10-4F10-11, Bio X Cell BP0032) and anti-PD-L1 (Clone 10F.9G2 ...
-
bioRxiv - Biochemistry 2019Quote: ... 1 mM STF-1084 in PBS or PBS alone were injected intratumorally and 200 μg of anti-CTLA-4 antibody or Syrian hamster IgG antibody (both BioXCell) were injected intraperitoneally on day 2 ...
-
bioRxiv - Immunology 2023Quote: ... tumor-bearing mice were injected intraperitoneally with 100 μg of anti-CTLA-4 (clone UC10-4F10-11, Bio X Cell) and 100 μg of anti-PD-L1 (clone 10F.9G2 ...
-
bioRxiv - Synthetic Biology 2019Quote: Antibodies used for in vivo experiments include: anti-mouse PD-L1 (BioXCell cat: BE0101and anti-mouse CTLA-4 (BioXCell cat: BE0164). Pre-conjugated primary antibodies used for flow cytometry and microscopy include ...
-
bioRxiv - Cancer Biology 2020Quote: ... were used for checkpoint blocking on tumors as well as T cells: functional grade PD-L1 (29E.2A3) and CTLA-4 (BN13) (Bioxcell, USA). In brief ...
-
bioRxiv - Immunology 2021Quote: ... – and in vivo ICI treatment – anti-mouse PD-1 (RMP1-14) and anti-mouse CTLA-4 (9D9) – were purchased from Bio X Cell (USA). For T cell depletion ...
-
bioRxiv - Cancer Biology 2023Quote: ... with each group receiving either PBS or RGS (100 mg/kg/day) or CTLA-4 mAb (10 mg/kg, twice a week; Bio X Cell, BE0032) or corresponding isotype (Bio X Cell ...
-
bioRxiv - Cancer Biology 2021Quote: Six month old KRC mice were enrolled onto the anti CTLA-4 treatment trial and treated with either anti-CTLA4 antibody (clone 9H10; Bio X Cell, Lebanon, NH) or InVivoPlus Syrian hamster IgG isotype control antibody (Cat# BP0087 ...
-
bioRxiv - Immunology 2019Quote: ... anti-human CD3 (OKT3, Bio X cell, anti-human CD28 (9.3 Bio X Cell), anti-human CD45 (REA747 ...
-
bioRxiv - Immunology 2019Quote: ... anti-human CD3 (OKT3, Bio X cell, anti-human CD28 (9.3 Bio X Cell), anti-human CD45 (REA747 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-human CD3 antibody (BioXCell) was added at a final concentration of 1 μg/106 cells to avoid potential graft-versus-host disease ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-human CD3 antibody (BioXCell) was added at a final concentration of 1 μg/106 cells to avoid potential graft-versus-host disease ...
-
bioRxiv - Microbiology 2021Quote: ... or human IgG1 isotype (BioXCell, #BE0297) (as negative control ...
-
bioRxiv - Immunology 2021Quote: ... human IgG1 isotype control (BE0297, BioXcell) at 50ug/mL ...
-
bioRxiv - Immunology 2021Quote: ... human IgG1 isotype control (BE0297, BioXcell) 25ug/mL ...
-
bioRxiv - Microbiology 2021Quote: ... or human IgG1 isotype control (BioXCell, #BE0297) for 30 min at 4°C ...
-
bioRxiv - Immunology 2020Quote: ... Anti-human IFNγ (Bio X Cell, BE0235) or anti-human CXCL10 (ThermoFisher Scientific ...
-
bioRxiv - Immunology 2020Quote: ... anti-human CD3(UCHT1, Bio X Cell) anti-mouse CD28(37.51 ...
-
bioRxiv - Immunology 2020Quote: ... and/or human CD8α (Bioxcell, OKT-8) three days prior to first treatment and concurrently with subsequent treatments.
-
bioRxiv - Immunology 2020Quote: ... and anti-human CD28(9.3, Bio X Cell) were used for T cell activation ...